Patents by Inventor John Corbin

John Corbin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODULATORS
    Publication number: 20260070972
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Application
    Filed: June 16, 2025
    Publication date: March 12, 2026
    Inventors: John Corbin, Mark Leslie White, Susan R. Watson, Vinay Bhaskar
  • ANTI-HLA-G ANTIBODIES, COMPOSITIONS COMPRISING ANTI-HLA-G ANTIBODIES AND METHODS OF USING ANTI-HLA-G ANTIBODIES
    Publication number: 20250353913
    Abstract: Provided herein are antibodies that selectively bind to HLA-G and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: February 27, 2025
    Publication date: November 20, 2025
    Inventors: Courtney Beers, John Corbin, Doug Hodges, Achim Moesta, Vanessa Soros, Paul Fredrick Widboom, Joseph Robert Warfield
  • Modulators
    Patent number: 12371488
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Grant
    Filed: January 13, 2022
    Date of Patent: July 29, 2025
    Assignee: XOMA (US) LLC
    Inventors: John Corbin, Mark Leslie White, Susan R. Watson, Vinay Bhaskar
  • Anti-HLA-G antibodies, compositions comprising anti-HLA-G antibodies and methods of using anti-HLA-G antibodies
    Patent number: 12264199
    Abstract: Provided herein are antibodies that selectively bind to HLA-G and and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Grant
    Filed: November 18, 2021
    Date of Patent: April 1, 2025
    Assignee: Tizona Therapeutics
    Inventors: Courtney Beers, John Corbin, Doug Hodges, Achim Moesta, Vanessa Soros, Paul Fredrick Widboom, Joseph Robert Warfield
  • ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTIBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES
    Publication number: 20250026850
    Abstract: Provided herein are antibodies with binding specificity for CD39 and compositions comprising the antibodies, including pharmaceutical compositions, diagnostic compositions and kits. Also provided are methods of using anti-CD39 antibodies for therapeutic and diagnostic purposes.
    Type: Application
    Filed: September 24, 2024
    Publication date: January 23, 2025
    Inventors: Vanessa Soros, Maria Kovalenko, John Corbin, Courtney Beers, Paul Fredrick Widboom, Joseph Robert Warfield
  • Human immunodeficiency virus neutralizing antibodies
    Patent number: 11655285
    Abstract: The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.
    Type: Grant
    Filed: December 3, 2020
    Date of Patent: May 23, 2023
    Assignee: Gilead Sciences, Inc.
    Inventors: Mini Balakrishnan, Brian A. Carr, John Corbin, Craig S. Pace, Nathan D. Thomsen, Xue Zhang
  • ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTIBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES
    Publication number: 20220372163
    Abstract: Provided herein are antibodies that selectively bind to CD39 and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: May 30, 2022
    Publication date: November 24, 2022
    Applicant: TRISHULA THERAPEUTICS, INC.
    Inventors: Vanessa SOROS, Maria KOVALENKO, John CORBIN, Courtney BEERS, Paul Fredrick WIDBOOM, Joseph Robert WARFIELD
  • ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTIBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES
    Publication number: 20220340680
    Abstract: Provided herein are antibodies with binding specificity for CD39 and compositions comprising the antibodies, including pharmaceutical compositions, diagnostic compositions and kits. Also provided are methods of using anti-CD39 antibodies for therapeutic and diagnostic purposes.
    Type: Application
    Filed: April 20, 2022
    Publication date: October 27, 2022
    Inventors: Vanessa Soros, Maria Kovalenko, John Corbin, Courtney Beers, Paul Fredrick Widboom, Joseph Robert Warfield
  • NOVEL MODULATORS
    Publication number: 20220227857
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Application
    Filed: January 13, 2022
    Publication date: July 21, 2022
    Inventors: John Corbin, Mark Leslie White, Susan R. Watson, Vinay Bhaskar
  • Anti-CD39 antibodies
    Patent number: 11345757
    Abstract: Provided herein are antibodies that selectively bind to CD39 and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: May 31, 2022
    Assignee: Trishula Therapeutics, Inc.
    Inventors: Vanessa Soros, Maria Kovalenko, John Corbin, Courtney Beers, Paul Fredrick Widboom, Joseph Robert Warfield
  • ANTI-HLA-G ANTIBODIES, COMPOSITIONS COMPRISING ANTI-HLA-G ANTIBODIES AND METHODS OF USING ANTI-HLA-G ANTIBODIES
    Publication number: 20220135689
    Abstract: Provided herein are antibodies that selectively bind to HLA-G and and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: November 18, 2021
    Publication date: May 5, 2022
    Inventors: Courtney Beers, John Corbin, Doug Hodges, Achim Moesta, Vanessa Soros, Paul Fredrick Widboom, Joseph Robert Warfield
  • Modulators
    Patent number: 11261247
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: March 1, 2022
    Assignee: XOMA (US) LLC
    Inventors: John Corbin, Mark Leslie White, Susan R. Watson, Vinay Bhaskar
  • ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTIBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES
    Publication number: 20210403593
    Abstract: Provided herein are antibodies that selectively bind to CD39 and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: September 7, 2021
    Publication date: December 30, 2021
    Inventors: Vanessa Soros, Maria Kovalenko, John Corbin, Courtney Beers, Paul Fredrick Widboom, Joseph Robert Warfield
  • Anti-HLA-G antibodies, compositions comprising anti-HLA-G antibodies and methods of using anti-HLA-G antibodies
    Patent number: 11208487
    Abstract: Provided herein are antibodies that selectively bind to HLA-G and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Grant
    Filed: September 26, 2019
    Date of Patent: December 28, 2021
    Assignee: Tizona Therapeutics
    Inventors: Courtney Beers, John Corbin, Doug Hodges, Achim Moesta, Vanessa Soros, Paul Fredrick Widboom, Joseph Robert Warfield
  • ANTI-HLA-G ANTIBODIES, COMPOSITIONS COMPRISING ANTI-HLA-G ANTIBODIES AND METHODS OF USING ANTI-HLA-G ANTIBODIES
    Publication number: 20210340259
    Abstract: Provided herein are antibodies that selectively bind to HLA-G and and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: September 26, 2019
    Publication date: November 4, 2021
    Inventors: Courtney Beers, John Corbin, Doug Hodges, Achim Moesta, Vanessa Soros, Paul Fredrick Widboom, Joseph Robert Warfield
  • HUMAN IMMUNODEFICIENCY VIRUS NEUTRALIZING ANTIBODIES
    Publication number: 20210155676
    Abstract: The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.
    Type: Application
    Filed: December 3, 2020
    Publication date: May 27, 2021
    Inventors: Mini Balakrishnan, Brian A. Carr, John Corbin, Craig S. Pace, Nathan D. Thomsen, Xue Zhang
  • ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES
    Publication number: 20210009708
    Abstract: Provided herein are antibodies that selectively bind to CD39 and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: July 30, 2018
    Publication date: January 14, 2021
    Inventors: Vanessa SOROS, Maria KOVALENKO, John CORBIN, Courtney BEERS, Paul Fredrick WIDBOOM, Joseph Robert WARFIELD
  • Human immunodeficiency virus neutralizing antibodies
    Patent number: 10882898
    Abstract: The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.
    Type: Grant
    Filed: February 12, 2019
    Date of Patent: January 5, 2021
    Assignee: GILEAD SCIENCES, INC.
    Inventors: Mini Balakrishnan, Brian A. Carr, John Corbin, Craig S. Pace, Nathan D. Thomsen, Xue Zhang
  • ANTI-HLA-G ANTIBODIES, COMPOSITIONS COMPRISING ANTI-HLA-G ANTIBODIES AND METHODS OF USING ANTI-HLA-G ANTIBODIES
    Publication number: 20200102390
    Abstract: Provided herein are antibodies that selectively bind to HLA-G and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: September 26, 2019
    Publication date: April 2, 2020
    Inventors: Courtney Beers, John Corbin, Doug Hodges, Achim Moesta, Vanessa Soros, Paul Fredrick Widboom, Joseph Robert Warfield
  • HUMAN IMMUNODEFICIENCY VIRUS NEUTRALIZING ANTIBODIES
    Publication number: 20190211083
    Abstract: The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.
    Type: Application
    Filed: February 12, 2019
    Publication date: July 11, 2019
    Applicant: Gilead Sciences, Inc.
    Inventors: Mini Balakrishnan, Brian A. Carr, John Corbin, Craig S. Pace, Nathan D. Thomsen, Xue Zhang